More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

The child is currently being treated at a trust-run hospital and his condition is stable, a medical officer said ...

Vomiting and diarrhoea are the most common symptoms of norovirus, and sufferers may also experience a high temperature, ...

But the percentage of people testing positive for HMPV out of those visiting participating GPs with symptoms of respiratory illness increased to 4.92 per cent by the middle of January 2025. This is ...

Flu is a viral infection affecting the nose, throat and lungs, mostly during the winter months. It is far worse than an ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

The DOH said that from January 1 to 18, 2025, there were 10,842 dengue cases recorded in the country, which was 8% lower than ...

It warned of illnesses including flu, Covid, RSV, norovirus, the less familiar hMPV and, of course, the common cold. With these viruses proving to be highly infectious and spreading rapidly, the UKHSA ...